Andrew Huberman· PhD
We do sometimes, but I do it with much more caution because I don't have the data, right.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We do sometimes, but I do it with much more caution because I don't have the data, right.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
as you alluded to earlier there is no FDA approval for testosterone in the use of women so there is for men of course • and there's obviously an FDA approval for estrogen and progesterone in the use of women